Adimmune Corp (4142.TW) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · Taiwan · ISIN TW0004142005
Adimmune Corp financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.56 bn TWD | 1.40 bn TWD |
| Gross profit | 448.06 m TWD | 288.49 m TWD |
| Operating income | -299.09 m TWD | -359.55 m TWD |
| EBIT | -300.00 m TWD | -359.55 m TWD |
| Net income | -242.75 m TWD | -239.89 m TWD |
| Diluted EPS – continuing operations | -0.58 TWD | -0.57 TWD |
Full history since 2007, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Adimmune Corp
Adimmune Corporation engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally. The company offers AdimFlu-S, a quadrivalent influenza vaccine; suspensions for injection influenza vaccines; and tetanus toxoid alum precipitated product for the prevention of tetanus after injury. It also develops AdimrSC-2f, a subunit protein-based vaccine for the prevention of COVID-19; H5N1 vaccine; and cell culture-derived Japanese encephalitis vaccine. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was incorporated in 1965 and is headquartered in Taichung, Taiwan.
More stocks
- CONSUMER PORTFOLIO SERVICES, INC. (CPSS)
- Solusi Sinergi Digital Tbk PT (WIFI.JK)
- Neo Corporate Pcl (NEO.BK)
- TOYO Co., Ltd Ordinary Shares (TOYO)
- Arizon RFID Tech (Cayman) Co (6863.TW)
- United Orthopedic (4129.TWO)
- Genesis Technology (6221.TWO)
- Alkindo Naratama Tbk (ALDO.JK)
- Kepler Weber S.A (KEPL3.SA)
- DingZing Advanced Materials Inc. (6585.TW)
- Tanvex BioPharma Inc (6541.TW)
- Xi S And D Inc (317400.KS)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.